Andrew Cittadine

Insider Reports History

Entity
Individual
Location
C/O 1000 Skokie Blvd Suite 350, Wilmette, IL
Signature
/s/ Quan Vu, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Cittadine:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Monopar Therapeutics Chief Operating Officer Common Stock 42K $1.53M $36.41 Mar 31, 2025 Direct
Monopar Therapeutics Chief Operating Officer Restricted Stock Units 51.7K $1.14M $22.00 Mar 4, 2025 Direct
Monopar Therapeutics Chief Operating Officer Stock Options 43.4K Mar 4, 2025 Direct
Monopar Therapeutics Chief Operating Officer Stock Options 25K May 22, 2024 Direct

Insider Reports Filed by Andrew Cittadine

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MNPR Monopar Therapeutics Mar 31, 2025 3 -$27.1K 4 Apr 2, 2025 Chief Operating Officer
MNPR Monopar Therapeutics Mar 4, 2025 2 $0 4 Mar 7, 2025 Chief Operating Officer
MNPR Monopar Therapeutics Dec 31, 2024 3 -$15.9K 4 Jan 2, 2025 Chief Operating Officer
MNPR Monopar Therapeutics Sep 30, 2024 3 -$3.61K 4 Oct 2, 2024 Chief Operating Officer
MNPR Monopar Therapeutics Jun 30, 2024 3 -$1.48K 4 Jul 2, 2024 Chief Operating Officer
MNPR Monopar Therapeutics Jun 18, 2024 2 $25.6K 4 Jun 21, 2024 Chief Operating Officer
MNPR Monopar Therapeutics Jun 13, 2024 3 $32.9K 4 Jun 17, 2024 Chief Operating Officer
MNPR Monopar Therapeutics Jun 3, 2024 2 $18.5K 4 Jun 5, 2024 Chief Operating Officer
MNPR Monopar Therapeutics May 29, 2024 3 $23.1K 4 May 31, 2024 Chief Operating Officer
MNPR Monopar Therapeutics May 22, 2024 1 $0 4 May 24, 2024 Chief Operating Officer
MNPR Monopar Therapeutics Mar 31, 2024 3 -$2.11K 4 Apr 2, 2024 Chief Operating Officer
MNPR Monopar Therapeutics Dec 31, 2023 3 -$1.05K 4 Jan 3, 2024 Chief Operating Officer
MNPR Monopar Therapeutics Sep 30, 2023 3 -$1.63K 4 Oct 3, 2023 Chief Operating Officer
MNPR Monopar Therapeutics Jun 30, 2023 3 -$3.47K 4 Jul 3, 2023 Chief Operating Officer
MNPR Monopar Therapeutics Mar 31, 2023 3 -$1.6K 4 Apr 4, 2023 Chief Operating Officer
MNPR Monopar Therapeutics Feb 1, 2023 2 $0 4 Feb 3, 2023 Chief Operating Officer
MNPR Monopar Therapeutics Dec 31, 2022 3 -$3.33K 4 Jan 3, 2023 Chief Operating Officer
MNPR Monopar Therapeutics Nov 14, 2022 2 $49.7K 4 Nov 16, 2022 Chief Operating Officer
MNPR Monopar Therapeutics Sep 30, 2022 3 -$1.81K 4 Oct 3, 2022 Chief Operating Officer
MNPR Monopar Therapeutics Jun 30, 2022 3 -$6.46K 4 Jul 1, 2022 Chief Operating Officer
MNPR Monopar Therapeutics Feb 2, 2022 2 $0 4 Feb 4, 2022 Chief Operating Officer
MNPR Monopar Therapeutics Jun 30, 2021 1 $0 4 Jul 2, 2021 Chief Operating Officer
MNPR Monopar Therapeutics Jun 1, 2021 1 $0 4 Jun 2, 2021 Chief Operating Officer
MNPR Monopar Therapeutics Jun 1, 2021 0 $0 3/A Jun 2, 2021 Chief Operating Officer